BDBM357015 US10214511, Example 19::US10676460, Example 19

SMILES Clc1nc(NCc2ccccn2)c2c(cccc2n1)-c1ccccc1

InChI Key InChIKey=JSYVMXAHYRRFOQ-UHFFFAOYSA-N

Data  50 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 50 hits for monomerid = 357015   

TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.01E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily A member 5(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  70nMAssay Description:Inhibition of human Kv1.5 transfected in mouse LTK cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetInsulin-like growth factor 1 receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.87E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Mus musculus (mouse))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.92E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5 activator 1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase I isoform alpha(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  2.55E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInsulin-like growth factor 1 receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.78E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  2.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Mus musculus (mouse))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PLK1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  50nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 8(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.19E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.01E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.15E+3nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInsulin-like growth factor 1 receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-1 receptor-associated kinase 4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.87E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Mus musculus (mouse))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.92E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5 activator 1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5 activator 1 [99-307](Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase I isoform alpha(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCasein kinase II subunit alpha'(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  2.55E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInsulin-like growth factor 1 receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.78E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  2.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase B(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PLK1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  50nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 8(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  1.19E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of human ERG expressed in HEK293 cells by thallium flux assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50:  5.15E+3nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In DepthDetails US Patent